PATENT CLAIM ANALYSIS

Application Number: 15774868
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "043000"]

Abstract:
The present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Claim (Index 28):
The method of  claim 27 , wherein said disorder is selected from the group consisting of: inflammation; fibrosis; septic shock; cancer; autoimmune diseases; metabolic disorders; heart disease; heart failure; pathological angiogenesis; ocular angiogenesis; a disease or condition associated with ocular angiogenesis; neovascularization related to cancer; proliferative vitreoretinopathy; and eye diseases.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 93.0
- Lexical Diversity: 2.60606
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15535837', '15323967', '11561465', '13266960', '14053797']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.831941704431403
- 35 USC 102 Novelty (BERT): 0.550580770537782
- Combined Prediction Score: 0.803805611042041
- Mean Citation Score: 372.047512
- Max Citation Score: 462.77826
- Similarity Product: 280.01059139182803

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test